Stocks Result Analysis for Industry - Biotechnology for Q4 FY24-25 ending Mar 31, 2025

Analysis of which stocks have performed the best and worst in Industry - Biotechnology for Q4 FY24-25 on the basis of sales/revenues, profits and profit margins. Only companies which have declared results in the current quarter are considered.

Choose Stock universe, Portfolio or index

Note: Industry-level growth metrics have been calculated by totaling the numbers of all companies in that industry, to get an average.

3
POSITIVE PROFIT GROWTH
5
NEGATIVE PROFIT GROWTH
0
NEUTRAL PROFIT GROWTH
13.8 %
TOTAL REVENUE GROWTH
20.0 %
TOTAL EBIDT GROWTH
16.5 %
TOTAL OPER. PROFIT GROWTH
 Positive  Negative  Pending
Stock Market Capitalization Operating Revenue Qtr Revenue Growth Qtr YoY % Revenue Surprise Qtr % Net Profit Qtr Net Profit Qtr Growth YoY % Net Profit Surprise Qtr % Operating Profit Qtr Operating Profit Growth Qtr YoY % EBITDA Qtr EBITDA Qtr growth YoY % Operating Profit Margin Qtr % Operating Profit Qtr Margin% YoY Change Last Result Updated
Alpa Laboratories 212.24 - - 29-May-2025
Biocon 40388.18 0.00 - 08-May-2025
Panacea Biotec 2798.24 - - 30-May-2025
Vivo Bio Tech 61.37 - - 19-May-2025
Genomic Valley Biotech 14.13 - - 31-May-2025
Shree Ganesh Bio-Tech 35.08 - - 22-May-2025
Advanced Enzyme 3441.47 - - 13-May-2025
Concord Biotech 19626.00 14.85 22.88 29-May-2025
Powered by Source: trendlyne.com